Constipation Clinical Trials

A listing of Constipation medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Athens Alabama

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

UPDATED

Birmingham Alabama

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

UPDATED

Birmingham Alabama

Patients are needed to participate in a clinical research study of Plecanatide and Placebo to evaluate Irritable Bowel Syndrome Characterized by Constipation (IBS-C)

UPDATED

Dothan Alabama

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

UPDATED

Foley Alabama

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

View More ▼

UPDATED

Guntersville Alabama

Patients are needed to participate in a clinical research study of Plecanatide and Placebo to evaluate Irritable Bowel Syndrome Characterized by Constipation (IBS-C)

UPDATED

Huntsville Alabama

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

UPDATED

Huntsville Alabama

Patients are needed to participate in a clinical research study of Plecanatide and Placebo to evaluate Irritable Bowel Syndrome Characterized by Constipation (IBS-C)

UPDATED

Montgomery Alabama

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

UPDATED

Saraland Alabama

Patients are needed to participate in a clinical research study of Plecanatide and Placebo to evaluate Irritable Bowel Syndrome Characterized by Constipation (IBS-C)

Birmingham Alabama 35233

A clinical research study of Lubiprostone and Placebo for the treatment of Constipation - Functional

Birmingham Alabama 35216

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Birmingham Alabama 35242

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Birmingham Alabama 35215

Patients are needed to participate in a clinical research study evaluating DDP733 for the treatment of Irritable Bowel Syndrome

Birmingham Alabama 35242

Patients are needed to participate in a clinical research study of Plecanatide to evaluate Chronic Idiopathic Constipation (CIC)

Dothan Alabama 36305

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Dothan Alabama 36305

Patients are needed to participate in a clinical research study of Plecanatide to evaluate Chronic Idiopathic Constipation (CIC)

Foley Alabama 36535

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Gulf Shores Alabama 36542

Patients are needed to participate in a clinical research study of Plecanatide to evaluate Chronic Idiopathic Constipation (CIC)

Huntsville Alabama 35802

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Huntsville Alabama 35801

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Huntsville Alabama 35801

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Huntsville Alabama 35801

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Huntsville Alabama 35802

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Huntsville Alabama 35801

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Huntsville Alabama 35801

Patients are needed to participate in a clinical research study evaluating DDP733 for the treatment of Irritable Bowel Syndrome

Huntsville Alabama 35801

Patients are needed to participate in a clinical research study evaluating DDP733 for the treatment of Irritable Bowel Syndrome

Huntsville Alabama 35801

Patients are needed to participate in a clinical research study evaluating Linaclotide and Matching Placebo for the treatment of Irritable Bowel Syndrome With Constipation (IBS-C)

Huntsville Alabama 35801

Patients are needed to participate in a clinical research study of Plecanatide to evaluate Chronic Idiopathic Constipation (CIC)

Mobile Alabama 36617

Patients are needed to participate in a clinical research study evaluating DDP733 for the treatment of Irritable Bowel Syndrome

Saraland Alabama 36571

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Arizona

Elite Clinical Studies, LLC
Phoenix Arizona 85018

Abdominal Pain related to Constipation? Suffer frequent Bloating or Cramping?

View More ▼

UPDATED

Chandler Arizona

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

UPDATED

Glendale Arizona

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

UPDATED

Glendale Arizona

Patients are needed to participate in a clinical research study of Plecanatide and Placebo to evaluate Irritable Bowel Syndrome Characterized by Constipation (IBS-C)

UPDATED

Phoenix Arizona

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

UPDATED

Phoenix Arizona

Patients are needed to participate in a clinical research study of Plecanatide and Placebo to evaluate Irritable Bowel Syndrome Characterized by Constipation (IBS-C)

UPDATED

Surprise Arizona

Patients are needed to participate in a clinical research study of Plecanatide and Placebo to evaluate Irritable Bowel Syndrome Characterized by Constipation (IBS-C)

UPDATED

Tucson Arizona

A Phase 3 clinical study for patients with Irritable Bowel Syndrome Characterized by Constipation

UPDATED

Tucson Arizona

Patients are needed to participate in a clinical research study of Plecanatide and Placebo to evaluate Irritable Bowel Syndrome Characterized by Constipation (IBS-C)

Chandler Arizona 85224

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Chandler Arizona 85224

Patients are needed to participate in a clinical research study of Plecanatide to evaluate Chronic Idiopathic Constipation (CIC)

Peoria Arizona 85381

Patients are needed to participate in a clinical research study evaluating DDP733 for the treatment of Irritable Bowel Syndrome

Phoenix Arizona 85008

A clinical research study of Lubiprostone and Placebo for the treatment of Constipation - Functional

Phoenix Arizona 85008

A clinical trial seeking patients for a research study for the treatment of Constipation - Functional

Phoenix Arizona 85018

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Phoenix Arizona 85018

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Phoenix Arizona 85018

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Phoenix Arizona 85018

A clinical trial to evaluate treatments using Tenapanor and Placebo for patients with Constipation Predominant Irritable Bowel Syndrome (IBS-C)

Phoenix Arizona 85018

Patients are needed to participate in a clinical research study evaluating Linaclotide and Matching Placebo for the treatment of Irritable Bowel Syndrome With Constipation (IBS-C)